108 related articles for article (PubMed ID: 23261075)
1. Profound hypertriglyceridemia and weight gain in the first week following initiation of olanzapine: a case report with implications for lipid monitoring guidelines.
Kimmel RJ; Levy MR
Psychosomatics; 2013; 54(4):392-4. PubMed ID: 23261075
[No Abstract] [Full Text] [Related]
2. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole for the management of olanzapine-induced weight gain.
Englisch S; Weinbrenner A; Inta D; Zink M
Pharmacopsychiatry; 2009 Jul; 42(4):166-7. PubMed ID: 19585397
[No Abstract] [Full Text] [Related]
4. Olanzapine-induced triglyceride and aminotransferase elevations without weight gain or hyperglycemia normalized after switching to aripiprazole.
Pawelczyk T; Pawelczyk A; Rabe-Jablonska J
J Psychiatr Pract; 2014 Jul; 20(4):301-7. PubMed ID: 25036587
[TBL] [Abstract][Full Text] [Related]
5. Refractory restless legs syndrome likely caused by olanzapine.
Khalid I; Rana L; Khalid TJ; Roehrs T
J Clin Sleep Med; 2009 Feb; 5(1):68-9. PubMed ID: 19317385
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
Chen CH; Huang MC; Lu ML
J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
[No Abstract] [Full Text] [Related]
7. Photo-onycholysis caused by olanzapine and aripiprazole.
Gregoriou S; Karagiorga T; Stratigos A; Volonakis K; Kontochristopoulos G; Rigopoulos D
J Clin Psychopharmacol; 2008 Apr; 28(2):219-20. PubMed ID: 18344734
[TBL] [Abstract][Full Text] [Related]
8. What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?
Deng C; Chen J; Hu C; Huang XF
J Clin Psychopharmacol; 2010 Aug; 30(4):480-1. PubMed ID: 20631576
[No Abstract] [Full Text] [Related]
9. Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
Wang LJ; Ree SC; Huang YS; Hsiao CC; Chen CK
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():260-6. PubMed ID: 23085073
[TBL] [Abstract][Full Text] [Related]
10. Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series.
Tolliver BK; McRae AL; Verduin ML; Anderson SJ; Brady KT
J Clin Psychopharmacol; 2008 Aug; 28(4):464-7. PubMed ID: 18626281
[No Abstract] [Full Text] [Related]
11. Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.
Markham-Abedi C; de Leon J
J Clin Psychiatry; 2006 Sep; 67(9):1473-4. PubMed ID: 17017841
[No Abstract] [Full Text] [Related]
12. Aripiprazole in a patient susceptible to urinary side effects of antipsychotics.
Sahoo S
Isr J Psychiatry Relat Sci; 2007; 44(1):74-5. PubMed ID: 17668467
[No Abstract] [Full Text] [Related]
13. Second-generation antipsychotics cause weight gain in youths.
Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
[No Abstract] [Full Text] [Related]
14. Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.
Lorenz RA; Weinstein B
J Clin Psychopharmacol; 2007 Oct; 27(5):524-5. PubMed ID: 17873694
[No Abstract] [Full Text] [Related]
15. Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice.
Ketter TA; Haupt DW
Curr Med Res Opin; 2006 Dec; 22(12):2345-53. PubMed ID: 17257449
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism.
eder-Ischia U; Ebenbichler C; Fleischhacker WW
Essent Psychopharmacol; 2005; 6(2):112-7. PubMed ID: 15765795
[TBL] [Abstract][Full Text] [Related]
17. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Perlis RH
Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia.
Fleischhacker WW; McQuade RD; Marcus RN; Archibald D; Swanink R; Carson WH
Biol Psychiatry; 2009 Mar; 65(6):510-7. PubMed ID: 18986646
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
Han M; Deng C; Burne TH; Newell KA; Huang XF
Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
[TBL] [Abstract][Full Text] [Related]
20. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
Lee SY; Park MH; Patkar AA; Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
